Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, and Bladder and Urothelial Cancer Treatments.
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture
Solving the :: Fusion Nomenclature Challenge for File and Directory Naming
A vision to the future: value-based laboratory medicine
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary <i>PIK3CA</i> Mutations
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML
Real‐world data for precision cancer medicine—A European perspective
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
Prognostic biomarkers for survival in mucosal melanoma
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations
Development of oil-based gels as versatile drug delivery systems for pediatric applications
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung Cancer
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer
A rapid genotyping panel for detection of primary central nervous system lymphoma
Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance